Fmoc-L-Lys(Boc, iPr)-OH is an Fmoc-protected, amino-acid derivative of L-lysine featuring a side-chain bearing both a Boc-protected amino group and an isopropyl (iPr) substituent, with a free carboxylic acid group. The molecule contains the Fmoc carbamate on the α-amino functionality and a Boc carbamate on the ε-amino side chain, while the iPr substitution modifies the lysine ε-position to alter steric and hydrogen-bonding characteristics relative to unmodified lysine. As a protected amino acid building block, it is used in stepwise peptide synthesis and related peptide-derivative preparation where orthogonal protection and controlled chemoselectivity are required for sequential coupling and side-chain handling.
CAT No: CP25561
CAS No:201003-48-7
Synonyms/Alias:201003-48-7;N-Fmoc-N'-Boc-N'-isopropyl-L-lysine;Fmoc-Lys(ipr,Boc)-OH;AmbotzFAA1447;Fmoc-Lys(Boc)(isopropyl)-OH;MolPort-008-267-661;ZINC15721389;AKOS016014587;AJ-67806;AK131100;KB-258783;ST24048568;N-Fmoc-N'-Boc-N'-isopropyl-L-lysine;Fmoc-Lys(ipr,Boc)-OH;Fmoc-Lys(Boc)(isopropyl)-OH;Fmoc-L-Lys(Boc, iPr)-OH;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-ylamino]hexanoic acid;L-Lysine, N6-[(1,1-dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-N6-(1-methylethyl)-;MFCD00080276;N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-(tert-butoxycarbonyl)-N6-isopropyl-L-lysine;CGA4VYL3H4;Fmoc-Lys(Boc,Isopropyl)-OH;DTXSID50679801;C29H38N2O6;BCP14624;AKOS016014587;DS-6846;HY-W043473;(S)-2-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-6-((Tert-Butoxycarbonyl)(Isopropyl)Amino)Hexanoic Acid;N6-[(1,1-DIMETHYLETHOXY)CARBONYL]-N2-[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]-N6-(1-METHYLETHYL)-L-LYSINE;CS-0036476;F10731;S-201003-48-7;(2S)-6-[(TERT-BUTOXYCARBONYL)(ISOPROPYL)AMINO]-2-{[(9H-FLUOREN-9YL-METHOXY)CARBONYL]AMINO}HEXANOIC ACID;(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)(isopropyl)amino)hexanoic acid;N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-t-butyl-oxycarbonyl-N-epsilon-i-propyl-L-lysine (Fmoc-L-Lys(Boc,iPr)-OH);N6-(tert-Butoxycarbonyl)-N2-{[(9H-fluoren-9-yl)methoxy]carbonyl}-N6-propan-2-yl-L-lysine
Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-t-butyloxycarbonyl-N-epsilon-i-propyl-L-lysine
Fmoc-L-Lys(Boc, iPr)-OH is an Fmoc-protected lysine derivative bearing a Boc-protected ε-amino group and an iPr-substituted side-chain functionality characteristic of a sterically tuned lysine analog. The molecule contains a chiral α-carbon typical of L-lysine, a phenylmethoxycarbonyl (Fmoc) group on the α-amine for orthogonal solid-phase peptide synthesis compatibility, and a carboxylic acid handle for peptide coupling or further derivatization. The Boc group on the side-chain amine provides acid-labile protection, while the iPr-bearing side-chain substituent can influence sterics, solubility, and downstream functionalization patterns. This protected amino acid ester-free building block is engineered for controlled deprotection and coupling chemistry, serving as a chiral intermediate in peptide construction and amino acid modification workflows.
1. Peptide Synthesis
Fmoc-L-Lys(Boc, iPr)-OH is applied in peptide building block preparation for automated solid-phase peptide synthesis and related coupling workflows where orthogonal protection is required. The Fmoc group enables base-mediated α-amino deprotection, while the Boc-protected ε-amino functionality remains protected under typical Fmoc removal conditions, supporting selective side-chain handling. The carboxylic acid participates in standard peptide coupling chemistry to install the lysine analog at defined chain positions, and the L stereochemistry preserves stereochemical integrity during chain assembly. Downstream peptide analogs can be generated with controlled ε-amino availability after Boc removal, enabling segment synthesis, protected peptide fragment preparation, and stepwise construction of lysine-containing sequences.
2. Side-Chain Functionalization
Fmoc-L-Lys(Boc, iPr)-OH supports amino acid derivatization strategies that target lysine side-chain chemistry while maintaining orthogonal protection for sequential transformations. The Boc-protected side-chain amine can be deprotected under acid conditions to reveal a reactive ε-nucleophile for acylation, carbamate formation, urea/amide coupling, or conjugation chemistry. The iPr-substituted side-chain environment can modulate nucleophilicity and steric accessibility, which may be leveraged to tune reactivity in side-chain functionalization and peptidomimetic design. The resulting functionalized lysine derivatives can be used to generate libraries of modified peptides, to construct chemically defined linkers, or to prepare intermediates for further heteroatom introduction and downstream scaffold elaboration.
3. Chemical Biology Conjugation
Fmoc-L-Lys(Boc, iPr)-OH is suitable for chemical biology workflows that require controlled installation of lysine-derived handles into peptides and biomolecule-reactive constructs. The orthogonal protection pattern allows sequential exposure of the ε-amino group for conjugation reactions while the Fmoc group supports incorporation into peptide backbones with defined stereochemistry. The protected carboxyl functionality enables peptide coupling to generate conjugation-ready peptide segments, and the side-chain deprotection step can provide a primary amine for labeling, affinity-tag attachment, or linker formation. Downstream products include labeled peptide probes, bioconjugation intermediates, and chemically characterized constructs used for molecular recognition studies and biomolecule modification.
4. Peptidomimetics And SAR
Fmoc-L-Lys(Boc, iPr)-OH can be employed in peptidomimetic construction and structure-activity relationship studies where lysine-like spacing and side-chain sterics are tuned. The α-amino protection (Fmoc) and ε-amino protection (Boc) enable incorporation into analog series with consistent protection/deprotection logic, supporting systematic variation of side-chain properties. The iPr-substituted feature provides a handle for modulating hydrophobic character and conformational preferences relative to canonical lysine derivatives, which can be reflected in analog libraries synthesized for SAR investigations. The compound thereby functions as a chiral, protected intermediate for generating series of peptide analogs and non-natural lysine-containing scaffolds amenable to comparative chemical characterization.
5. Pharmaceutical Manufacturing Intermediates
Fmoc-L-Lys(Boc, iPr)-OH is relevant to pharmaceutical manufacturing contexts where protected amino acid intermediates are used in controlled peptide or peptide-like ingredient synthesis. The Fmoc/Boc orthogonality supports manufacturing-friendly protection logic for stepwise assembly and purification of defined intermediates, reducing cross-reactivity between α- and side-chain functionalities. The presence of a single carboxylic acid group facilitates reliable conversion into activated coupling forms within synthetic routes that prepare peptide segments or final peptide products. Downstream use includes preparation of defined, stereochemically consistent lysine analog components for scale-up chemical manufacturing, process development studies, and fine chemical synthesis of peptide-based materials.
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.